Tactile Systems Technology

Lymphedema Tailwinds And AI Workflow Efficiencies Will Drive Significant Long Term Upside

AnalystHighTarget

Not Invested

Community Contributor

Published

12 Dec 25

Views

12 Dec

US$27.49

AnalystHighTarget's Fair Value

US$32.00

14.1% undervalued

166.4%

6.4%

166.4%

6.4%

Author's Valuation

US$3214.1% undervalued

AnalystHighTarget Fair Value

Valuator

Company Info

Notes

AnalystHighTarget Fair Value

US$32

14.1% undervalued

Future estimation in

Revenue

Profit Margin

Future PE

Growth p.a.

Decrease

Increase

Forecast revenue growth rate

8.38%

Historical revenue growth rate

10.69%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.48%

Calculation

US$38.84m

Earnings '28

19.54x

PE Ratio '28

US$759.04m

Market Cap '28

US$759.04m

Market Cap '28

18.97m

No. shares '28

US$40.01

Share Price '28

US$40.01 Share Price '28

Discounted to 2025 @ 7.73% p.a.

US$32.00

Fair Value '25